MedTrace Logo

Constipation Associated With Irritable Bowel Syndrome (IBS-C)

NCT00796354 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2010-02-17

No results posted yet for this study

Summary

Multi-centre, double-blind, randomised, placebo-controlled, parallel group study.

Conditions

Interventions

DRUG

MOVICOL

sealed laminated sachet, 1 - 3 sachets daily for 4 weeks

DRUG

Sugar Pill

sealed laminated sachet, 1 - 3 sachets daily for 4 weeks

Sponsors & Collaborators

Principal Investigators

  • Roger Chapman, MD · Oxford University Hospitals NHS Trust

  • Mike Geraint, MD · Norgine Pharmaceuticals Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Czechia
  • France
  • Germany
  • Italy
  • Poland
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00796354 on ClinicalTrials.gov